• Skip to main content
  • Skip to navigation
Site name
Site name
Mast navigation
  • Become a member
  • Sign In
Search our site
Menu
Close menu
  • Home
  • News
  • Oncology
  • AI
  • Topics
    • Back to parent navigation item
    • Topics
    • Technology
    • Resources
    • Diseases
    • Drugs and therapies
    • Research and development
    • Tools and techniques
    • Business
  • Webinars
  • Whitepapers
  • Reports
  • Home
  • News
  • Oncology
  • AI
  • Topics
      • Technology
      • Resources
      • Diseases
      • Drugs and therapies
      • Research and development
      • Tools and techniques
      • Business
    • Conference Hall
      AACR 2026 part two: integrating AI, spatial biology and next-gen therapeutics
    • AACR 2
      AACR 2026 part one: AI design, precision biology and the next wave of oncology innovation
    • 16_Still01_Bo and Lexi looking at computer_cleaned
      When scale meets insight: reinventing SPR for the future of drug discovery
  • Webinars
  • Whitepapers
  • Reports
  • More navigation items

Premium members qualification

  • No comments

Topics

  • Neurological disorders
  • No comments

Related articles

  • shutterstock_2757662219
    News

    AI-powered $6M project targets new Alzheimer’s treatments

    2026-06-16T12:47:00Z

    By Drug Target Review

  • shutterstock_2453832179
    News

    Copper drug Cu(ATSM) reduces Alzheimer’s proteins by 42 percent in preclinical study

    2026-06-15T12:35:00Z

  • shutterstock_2695898955
    News

    Cytokine-armoured CAR T cells target glioblastoma while reducing treatment toxicity

    2026-06-12T11:50:00Z

    By Drug Target Review

  • shutterstock_2082217543
    News

    Study suggests senolytic therapies could slow spinal disc degeneration

    2026-06-05T09:00:00Z

    By Drug Target Review

  • shutterstock_2579142623
    News

    Organoid study reveals valproate’s impact on developing brain

    2026-05-27T08:59:00Z

    By Drug Target Review

  • shutterstock_2084522077
    Article

    Beyond tangles: why soluble intracellular tau should guide drug discovery

    2026-05-27T07:00:00Z

    By Professor Marc Aurel Busche

No comments yet

You're not signed in.

Only registered users can comment on this article.

Sign in Register

Partner content

  • CELLVO~1
    Webinar

    What it takes to automate high-content imaging at scale

    2026-03-25T15:00:00 2026-03-25T16:00:00

    Sponsored by Yokogawa

  • Computer,Screen,With,Molecular,Modelling,Software,Simulating,Proteins,,Designing,New
    Webinar

    The truth about AI in drug discovery: what the experts really think

    2026-03-11T14:00:00

    Sponsored by Merck

  • shutterstock_2771790713
    Article

    Women in STEM: resilience and leadership in rare disease research

    2026-05-19T09:46:00

    Contributor Dr Nitza Thomasson

  • Takara Bio Asset 2 Feature Image
    Whitepaper

    Guide: Create DNA Template for In Vitro mRNA Synthesis

    2025-04-22T14:58:00

    Sponsored by Takara Bio USA

  • Takara Bio Asset 3 Feature Image
    Whitepaper

    App Note: High-Throughput Single-Cell Genome Profiling

    2025-05-08T10:38:52

    Sponsored by Takara Bio USA

  • Doctor,Hold,Vaccine,Bottle,Vial,In,Laboratory,With,On,Hologram
    Webinar

    AI-powered drug discovery: Accelerating the development of life-saving therapies

    2025-09-18T12:00:00

    Sponsored by Benchling

  • Topics
  • Technology
  • Resources
  • Diseases
  • Drugs and therapies
  • Research and development
  • Tools and techniques
  • Business
  • Advertising & Editorial
  • Advertising opportunities
  • Media planner
  • Advertising tech specs
  • Information for authors
  • Reuse policy
  • Information
  • About us
  • Company information
  • Careers
  • Terms and conditions
  • Privacy policy
  • Cookie policy
The trusted voice in drug discovery
Find us on social media:
  • Topics A-Z
  • Writers A-Z
  • © 2026 Drug Target Review

Site powered by Webvision Cloud